TNXP - Tonix Pharma Qarzning balans kapitallashuviga nisbati

Tonix Pharma (TNXP) grafik logotipi

Tonix Pharmaceuticals (TNXP) infeksiyalar va og'riq sindromlariga qarshi kurashish usullarini ishlab chiqayotgan ko'p qirrali biofarmatsevtika brendi sifatida joylashgan bo'lib, joriy ko'rsatkich 0.01 ni tashkil etadi. Ushbu narxlar grafigi aktivning narx harakatini aks ettiradi, uning kelajakdagi daromadlari PTSD va fibromialgiya terapiyasi uchun Tonmya ning tijoratlashtirilishiga bog'liq. Operatsion faoliyat AQSh ichki tizimi doirasida himoyalangan bo'lib, bu kompaniyani global siyosiy mojarolardan xoli qiladi.

TNXP (Tonix Pharmaceuticals Holding) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

Tonix Pharma (TNXP) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Tonix Pharmaceuticals|TNXP - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Tonix Pharmaceuticals Holding|TNXP - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Tonix Pharmaceuticals|TNXP - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati tonixpharma.com|TNXP - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Tonix Pharmaceuticals|TNXP - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Tonix Pharmaceuticals Inc.|TNXP - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Tonix Pharmaceuticals Holding|TNXP - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Tonix Pharmaceuticals
Kompaniyaning barcha koʻrsatkichlari tahlili:TNXP Tonix Pharmaceuticals
Tonix Pharmaceuticals Inc. asosiy tovari

Ushbu ko'rsatkich biznesning bankrotlikka nisbatan chidamliligini baholash uchun umumiy majburiyatlarni kapitalga nisbatan taqqoslaydigan moliyaviy leverajni o'lchaydi. GURU.Markets balans hisobotidagi qarzning kapitalizatsiyaga nisbati tahlili orqali investor Tonix Pharmaceuticals (TNXP) kompaniyasi birlashmalar yo'qligi va organik aktivlarni himoya qilish strategiyasi sharoitida qarzlar va davlat grantlari muvozanatini qanday ta'minlashini ko'rishi mumkin.

Tonix Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati sxtchina.com SXTC|Qarzning balans qiymatiga nisbati Eupraxia Pharmaceuticals Inc. (EPRX)|BioHarvest Sciences, Inc. - Qarzning balans kapitaliga nisbati|EXOZ (Invizyne Technologies, Inc.) - Qarzning balans kapitallashuviga nisbati|ORMP: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati enterabio.com|ipatherapeutics.com (HYFT) - Qarzning balans qiymatiga nisbati|ABVC: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Cumberland Pharmaceuticals Inc (CPIX)|Qarzning balans qiymatiga nisbati Quantum BioPharma Limited QNTM|Qarzning balans qiymatiga nisbati FibroGen Corporation FGEN|Qarzning balans qiymatiga nisbati Telomir Pharmaceuticals|Rani Therapeutics Holdings - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Synergy CHC Corporation|RLYB - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar lexariabioscience.com LEXX|Pulmatrix Corporation (PULM) - Qarzning sof aktivlarga nisbati|PTHL (Pheton Holdings Limited) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar APM|Lyra Therapeutics (LYRA) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati IBO (Impact BioMedical, Inc.)|TNF Pharmaceuticals, Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati cbdMD Inc. YCBD|PainReform Ltd. - Balans kapitallashuviga qarzlar|CYTO - Balans kapitallashuviga qarzlar|LIPO (Lipella Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|OptiNose Inc (OPTN) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PIRS (Pieris)|Balans qiymatiga qarzlar Procaps Group Corp (PROC)|Qarzning balans qiymatiga nisbati PTPI|Balans kapitallashuviga qarzlar qlsyy.net QLI|Qarzning balans qiymatiga nisbati ACELYRIN (SLRN)|Qarzning balans kapitaliga nisbati TFF Pharmaceuticals Inc. TFFP